Archer Materials Limited (AU:AXE) has released an update.
Archer Materials Limited has achieved significant advancements in its quantum technology and biochip projects in the third quarter of FY24, including the development of a new pulsed electron spin resonance chip and the miniaturization of its biochip design. The company boasts a strong financial position with $20 million in cash reserves and no debt, and it looks forward to the delivery of the new biochips in mid-2024. These developments are expected to enhance Archer’s footprint in the quantum computing and medical diagnostics industries.
For further insights into AU:AXE stock, check out TipRanks’ Stock Analysis page.
